2m 2m 2m 2m 2m 2m 2m
BioAffinity (BIAF)
NASDAQ
$1.66-$0.03 (-1.66%)
Price as of Jun 03, 2026 7:50 PM EDT- $7.6MMarket Cap
- -80.18%1-Year Change
- Diagnostics & ResearchIndustry
BioAffinity (BIAF)
$1.66-$0.03 (-1.66%)
BIAF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.69 | ||
Change | -$0.07 (-4.00%) | ||
Open | $1.66 | ||
High | $1.74 | ||
Low | $1.60 | ||
Previous Close | $1.68 | ||
Volume | 120,865 | ||
30-Day Average Volume | 220,599 | ||
1-Week Change | 1.82% | ||
1-Month Change | -23.29% | ||
1-Year Change | -80.18% | ||
3-Year Change | -96.92% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.5M | ||
Total Assets | $7.9M | ||
Market Cap | $7.6M | ||
Enterprise Value | $4.6M | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | N/A | ||
Free Cash Flow | -$3.2M | ||
EBIT | $0.00 | ||
EBITDA | $114,518.00 | ||
Net Working Capital | $1.2M | ||
EPS | -$0.81 | ||
Enterprise Value/EBITDA | 40 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 2 | ||
P/E | -2 | ||
PEG | N/A | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 09/19/2025 | ||
Earnings & Revenue